This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
LifeSpan Biosciences
product type :
antibody
product name :
Anti-Geminin Antibody (aa50-100) LS-C66459
catalog :
LS-C66459
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot, immunoprecipitation
product information
?AntibodyID :
67085
AntibodyName :
LS-C66459
TargetSpecies :
Human
Host Species :
Rabbit
Product Name :
Anti-Geminin Antibody (aa50-100) LS-C66459
Specificity :
Species cross-reactivity: Human. Other species not tested.
ClonalityDesc :
Polyclonal
AntibodyModification :
Unconjugated
AntigenModification :
aa50-100
PresentationDesc :
Tris-citrate/phosphate buffer, pH 7 to 8.
ImmunogenType :
Synthetic peptide
ImmunogenDesc :
This antibody maps to a region between residue 50 and 100 of human Geminin DNA replication Inhibitor using the numbering given in entry NP_056979.1 (GeneID 51053).
PurificationDesc :
Immunoaffinity purified
Gene :
Geminin
StandardGeneSymbol :
GMNN
Reactivity :
Human
Usage :
IP, WB
UsageText :
Suitable for use in Western Blot and Immunoprecipitation.
Synonyms :
GMNN, Geminin
ProductID :
78824
ProductNumber :
LS-C66459-100
Weight :
100 µg
company information
LifeSpan Biosciences
2401 Fourth Avenue, Suite 900
Seattle, WA 98121
antibodies@lsbio.com
www.lsbio.com
1-206-464-1554
headquarters: USA
Since 1995, LifeSpan has been the industry leader in molecular pathology, specializing in the localization of proteins in normal and diseased tissues, both human and non-human. We offer more than 74,000 antibodies, custom designed immunohistochemistry (IHC) studies, immediately available human tissue IHC profiles for more than 500 proteins, and histology and pathology services. Our bank of 2 million specimens is available to support our customers' contract research studies and contains frozen and formalin-fixed (FFPE) normal and diseased tissues. Our contract services are comprehensive; they include study design, antibody sourcing and characterization, tissue sourcing and validation, immunolabeling, trouble shooting, and interpretation of the results by a LifeSpan pathologist.